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Abstract
Plants have been utilized as herbicides, insecticides, antimicrobials, antifungals,
antivirals, cosmetics and therapeutic agents. Traditional medicine plays a pivotal role in health
care around the globe. Lepidium sativum (LS) has been utilized in cooking for its peppery, tangy
flavor and aroma and in traditional medicine. LS has been used to treat inflammation, bone
fractures, hypertension, microbial infections, diabetes, bronchial asthma, osteoarthritis,
constipation and other diseases. There have been no studies investigating the effects of LS seed
extracts on preovulatory surge secretion of gonadotropin releasing hormone (GnRH), luteinizing
hormone (LH) and follicle-stimulating hormone (FSH). The highest level of inclusion of LS
seeds at 50% has shown lethal effects. At 10% LS seed inclusion has shown ambiguous toxic
and non-toxic effects. There is a paucity of information on LS effects on female and male
reproductive function. To date, LS has been shown in females to act as a galactagogue,
abortifacient and contraceptive. There are ambiguous results of LS having anti-ovulatory
properties. In males, LS has been shown to increase testicular and epididymal sperm
concentration and act as an aphrodisiac. The objectives of the study were to determine the effect
of aqueous LS seed extract on the development and magnitude of surge releases of GnRH, LH
and FSH and secondly, to determine the acute and chronic effects of 15% LS seed
supplementation on gross organ morphology and histomorphometric indices, testosterone
secretion and spermatogenesis in the Sprague-Dawley rat.
Thirty-two female Sprague-Dawley rats were ovariectomized using standard procedures
for Experiment 1. Ten days post-ovariectomy, all rats were injected with estradiol-17β (10 μg/0.2
mL/rat, s.c. in corn oil) for three days. On the fourth day at 0800 h, sixteen rats were treated with
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LSE (40 mg/Kg BW, i.p.) while the remaining sixteen received normal saline diluent at the same
rate. At 1000 h, eight rats that received LSE and eight rats that received normal saline were
treated with corn oil (0.2 mL/rat, s.c.). The remaining sixteen rats were treated with progesterone
(2.5 mg/0.2 mL/rat, s.c. in corn oil). At 1300 h, the rats were euthanized using an overdose of 6
mL 2.5% tribromoethanol. The hypothalamus and pituitary glands were extracted and perifused
in artificial cerebrospinal fluid for seven hours at a constant temperature of 37°C. Hypothalamic
GnRH and pituitary LH and FSH concentrations were determined utilizing radioimmunoassays.
There were no significant differences in GnRH, LH or FSH secretions. There was an observed
GnRH surge in rats receiving saline and progesterone. Rats that received LSE and progesterone
observed an earlier and diminished secretion of GnRH, but was not significant. Progesterone
administration had a suppressive effect on LH average secretion. GnRH administration had no
effect on LH or FSH secretion. Total hormonal secretions for GnRH, LH and FSH had no
significant changes.
Forty-eight male Sprague-Dawley rats were utilized for Experiment 2. Upon arrival, rats
were given feed and water ad libitum for two weeks for acclimation. The rats were weighed and
assigned to either a control group (0% LS seed inclusion; n=24) or a treatment group (15% LS
seed inclusion; n=24). At 0800 h rats were offered either normal rat chow or the 15% LS seed
included rat chow for 8 weeks. At 2, 4, 6 and 8 weeks, six rats from each the Control or the
Treatment groups were euthanized with carbon dioxide asphyxiation for a minimum of 10minutes. All rats were weighed on the first day of the experiment, every other day and
immediately after euthanization. Every day feed intake and refusal was measured. Immediately
post euthanization, trunk blood was collected for hormone assays. Further, the paired testicles,
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epididymides, prostate gland, seminal vesicles, kidneys, adrenal glands, heart, liver, spleen,
lungs, brain and pancreas were harvested and weighed. The relative organ weights were
normalized to weight per 100 g BW. One kidney and one testis was collected and used for
histological analysis. The other testes were utilized for in vitro testosterone production. One
cauda epididymis per rat was isolated and used for epididymal sperm count. Our results indicated
a decrease in Treatment group’s body weight during the first few days of the experiment. This
occurred concurrent with a strong feed aversion for the Treatment group during the first few
days. This effect is explained by the novel food source being offered to the rats. There was no
effect of LS seed inclusion on adrenal gland, heart, liver, and spleen or lung weight. There was a
significant increase in brain weight possibly due to hydrocephalus. There was also a significant
increase in pancreatic weight possibly due to pancreatitis. There were no effects of LS
supplementation on paired testicular, epididymides or seminal vesicle weights. The prostate
gland did show a significant decrease in weight. The mechanism for this significant weight
decrease is unknown. The testis histological analysis had no significant results except for an
increase in week two Leydig cell diameter. There was no significant changes for in vitro
testosterone production or plasma testosterone. Therefore, our results suggest no conclusive data
for the aphrodisiac claims. The epididymal sperm density did not have significant changes,
although they did increase concurrent between the groups through the experiment. Interestingly,
there was an increase in renal weight through the experiment for the Treatment group.
Histological analysis showed a significant change in the diameter of the Bowman’s capsule,
glomerulus and Bowman’s space for the Treatment group. There was also an increase in
glomerulosclerosis, metaplasia and hyperplasia in rats fed 15% LS seed inclusion. In the
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proximal and distal tubules there was a significant increase in tubular degeneration throughout
the experiment. These results paired together show a significant toxic effect for rats fed 15% LS
seed. Overall, LS seed consumption for medicinal purposes should be consumed with caution
because of the possible narrow therapeutic index.
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Chapter I: Introduction
The first synthesized drug did not appear until 1869. The drug chloral hydrate was
utilized as a sedative-hypnotic (Jones, 2011). Prior to 1869 medicinal drugs were plant-derived.
The usage of plants in traditional medicine dates back nearly 60,000 years ago. At a Neanderthal
burial site in Shanidar, Iraq eight species of medicinal plants were exhumed with Neanderthal
bodies, seven of which are still utilized today for their medicinal properties (Solecki, 1975).
Apart as a food source, plants have been utilized as herbicides (Dayan & Duke, 2014),
insecticides (Zoubiri & Baaliouamer, 2014), antimicrobials (Upadhyay, Upadhyaya, KollanoorJohny, & Venkitanarayanan, 2014), antifungals (Trakranrungsie, 2011), antivirals (Babar, Zaidi,
Ashraf, & Kazi, 2013), cosmetics (Gediya, Mistry, Patel, Blessy, & Jain, 2011) and therapeutic
agents (Veeresham, 2012). Important drugs that have been derived from plants include digoxin,
quinine, quinidine, vincristine, vinblastine, atropine, morphine and codeine (Rates, 2001).
Approximately 80% of pharmaceuticals are derived from natural compounds or natural products
(Maridass & John De Britto, 2008). It is estimated that 50% of pharmaceuticals were first
identified from plants and other organisms (Krief, Martin, Grellier, Kasenene, & Sévenet, 2004).
It is estimated that there are 450,000 angiosperm species (Pimm & Joppa, 2015) and
about 1000 gymnosperms species (Christenhusz, et al., 2011). Of the existing plant species only
6% have been investigated for pharmacological properties and 15% have been investigated for
phytochemical properties (Atanasov, et al., 2015). That means only about 27,000 plants have
been systematically investigated for pharmacological properties and 68,000 plants for
phytochemical properties. When utilized in traditional medicine, plants first need to be extracted
to separate the medicinally-active chemicals utilizing selective solvents (Handa, Khanuja,
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Longo, & Rakesh, 2008). Extraction techniques include maceration, infusion, percolation,
decoction, Soxhlet, microwave-assisted, ultrasound-assisted, accelerated solvent and
supercritical fluid extraction (Azwanida, 2015). Depending on the solvent used different
compounds can be extracted. Nonpolar compounds can be extracted efficiently by hexane, 1chlorobutane, dichloromethane, chloroform, isopropyl ether, ethyl ether, ethyl acetate and 1butanol. Polar compounds need a polar solvent to efficiently extract the compounds (Siek, 1978).
Alcohols like ethanol and methanol utilized as solvents in extractions have proven to be more
efficient than water (aqueous extraction) in extracting phytochemicals (Gberikon, Adeoti, &
Aondoackaa, 2015).
Plant and animal-derived medicines are important because of the 252 essential chemicals
distinguished by the World Health Organization, 11.1% originate from plants while 8.7%
originate from animals (Costa-Neto, 2005). In 2007, it was reported that nearly 38% of adults
and 12% of children used some form of traditional medicine in the USA within a twelve month
period (Barnes, Bloom, & Nahin, 2008). In a recent survey, estimates for adults who have
utilized homeopathic remedies was 3.9% among USA, United Kingdom, Australia, Israel,
Canada, Switzerland, Norway, Germany, South Korea, Japan and Singapore (Relton, Cooper,
Viksveen, Fibert, & Thomas, 2017). Interestingly, it is estimated that at least 50% of the
populations in Europe, North American and other developed regions have used traditional
medicine at least once. In developing countries it is estimated that up to 80% of the population
utilizes traditional medicine as their primary health care (World Health Organization, 2003).
Traditional medicine is advantageous because of the ease of access and low cost. In many parts
of the world traditional medicine is also used in regular cultural traditions.
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Lepidium sativum (LS), commonly known as garden cress, is an annual and fast growing
herb (Panwar & Guha, 2014). LS belongs to the Brassicaceae family. It is utilized as a spice for
its peppery, tangy flavor and aroma. The plant grows up to 50 cm tall originating from 4 mm
long and 2 mm wide seeds. LS has been utilized in traditional medicine to treat inflammation,
bone fractures, hypertension, microbial infections, diabetes, bronchial asthma, osteoarthritis,
constipation and to increase milk production (Falana, Nofal, & Nakhleh, 2014). Although there
is a dearth of information on the efficacy, safety and mechanism of action for the utilization of
LS in traditional medicine there is a paucity of information on LS and its role in the control of
reproduction.
Reproduction in all mammals is regulated by the hypothalamic-pituitary-gonadal axis.
The hypothalamus sits atop the axis and secretes the decapeptide gonadotropin-releasing
hormone (GnRH). In both mammalian males and females, GnRH is secreted in a pulsatile
fashion. This pulsatility in turn leads to pulsatile secretion of luteinizing hormone (LH) and
follicle-stimulating hormone (FSH) which function to stimulate production of ovarian estrogen
and progesterone and testicular testosterone. LH and FSH also play a pivotal role in modulating
gametogenesis. In mammalian females only, there is an increased release of GnRH called the
surge secretion of GnRH. As with the pulsatile mode of secretion, the GnRH surge causes the
surge secretions of LH and FSH. The LH surge occurs immediately before and causes ovulation.
The neuroendocrine regulation of both pulsatile and surge secretions of GnRH and the
gonadotropins has been well-described (Plant & Zeleznik, 2015). Generally, it is known that
different hypothalamic areas regulate these two modes of hormonal synthesis and secretion and
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that all influences on reproduction, both internal and external, impact reproduction via these
hypothalamic areas.
To date, there have been no studies investigating the effects of LS seed extracts on
preovulatory surge secretion of GnRH, LH and FSH. Although it has been shown that 10% LS
supplementation in Wistar rats was nontoxic (Datta, Diwakar, Viswanatha, Murthy, & Naidu,
2011), questions have been asked about the exact physiologic or pharmacologic level of
inclusion of LS in animal feeds. Further, it is unclear what the consequences of this level of LS
inclusion for reproduction and somatic development might be. The objectives of the study are to
determine the effect of aqueous LS seed extract on the development and magnitude of surge
releases of GnRH, LH and FSH and secondly, to determine the acute and chronic effects of 15%
LS seed supplementation on gross organ morphology and histomorphometric indices,
testosterone secretion, and spermatogenesis in the Sprague-Dawley rat.
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Chapter II: Literature Review
Plant-Derived Medicine and their Contributions to the World
Plant-derived medicine plays a pivotal role in healthcare worldwide. Even though there
has been a recent increase over the past few decades in molecular modeling, combinatorial
chemistry and synthetic chemistry methods the plant derived medicinal compounds have played
a crucial source in the pharmaceutical industry (Salim, Chin, & Kinghorn, 2008). In 2001,
approximately 25% of all drugs prescribed originated from plants (Rates, 2001). On average it
takes about ten to twelve years for a drug to travel from the discovery stage to the market.
Interestingly, twelve years later about 45% of top selling drugs originated from natural products
in the environment (Lahlou, 2013). Apart from plant derivatives being utilized in the
pharmaceutical industry, they also play a pivotal role in primary health care in developing
countries.
Lepidium sativum: Botany, Distribution and Chemical Composition
Lepidium sativum (LS), commonly known as garden cress, is an annual, edible, fast
growing herb which belongs to the Brassicaceae family (Panwar, et al., 2014). LS is cultivated in
Africa, North America, parts of Europe (Nuez & Hernandez Bermejo, 1994) and India
(Nadkarni, 1976). The requirements for LS are simple and broad. This means the plant can grow
in moist soil with semi-shade or even in the absence of shade (Falana, et al. 2014). After sowing
the seeds, they will begin to sprout four to six days later. To ensure a continuous supply of LS
leaves farmers will sow the seeds in intervals of eight days (Wadhwa, Panwar, Agrawal, Saini, &
Patidar, 2012). LS is used as a culinary ingredient for its peppery, tangy flavor and aroma. The
seeds are small with a length ranging from 3-4 mm long and a width of 1-2 mm. They are
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smooth, oval-shaped, pointed and triangular at one end with a reddish brown color (Doke &
Guha, 2014).
LS seeds contain 22.7% of oil from a hexane extraction. The oil constituents revealed
oleic (30.6%), linolenic (29.3%), gondoic (11.1%), palmitic (9.4%) and linoleic acids (7.6%).
There was a large amount of the antioxidants γ- (1422 ppm), δ-(356 ppm) and α-tocopherols (21
ppm). The primary phytosterols include sitosterol (5.82 mg/g), campesterol (3.95 mg/g) and
avenasterol (3.44 mg/g). Other phytosterols include cholesterol (0.50 mg/g), stigmaterol (0.30
mg/g), dihydrolanosterol (0.25 mg/g) and β-amyrin (0.16 mg/g) (Moser, Shah, Winkler-Moser,
Vaughn, & Evangelista, 2009). Presence of carbohydrate and major sugars include mannose
(38.9%), arabinose (19.4%), galacturonic acid (8%), fructose (6.8%), glucuronic acid (6.7%),
galactose (4.7%), rhamnose (1.9%) and glucose (1.0%) (Karazhiyan, et al., 2009). LS seeds have
been shown to include the isoflavonoids 7-hydroxy-4’,5,6-trimethoxyisoflavone, 7-hydroxy-5,6dimethoxy-2’,3’-methylenedioxyisoflavone and 5,6-dimethoxy-2’,3’-methylenedioxy-7-C-β-Dgluco-pyranosyl isoflavone (Sakran, Selim, & Zidan, 2014). Gallic acid is utilized as a standard
for determining total phenolic content. This yields a gallic acid equivalent (GAE). Total
polyphenolic content for whole LS seeds are 2,081 mg GAE/100 g (Doke & Guha, 2015).
Ethanolic extract had evidence of cardiac glycosides, anthroquinone glycoside, cyanogenetic
glycoside, flavonoids, alkaloids, tannins, glycine, cysteine and glutamine (Yadav, Jain,
Srivastava, & Jain, 2011). The seeds contain benzylglucosinolate ~170 μmol/g dry weight. Eight
day old seedlings also contained isothiocyanate, thiocyanate and nitrile hydrolysis products
(Burow & Bergner, 2007). The β-carotene content was 433.41 μg/100 g. Zeaxanthin content was
2.35 μg/100 g. Lutein content was 96.21 μg/100 g. The total carotenoids content was 1.00
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μmol/100 g (Diwakar, 2010). Lepidine, an alkaloid, was found in the seeds at a content of 3.7
mg/g dry weight. Lepidine was highest in content within the plantlets during the vegetative stage
at 10.4 mg/g (Pande, Malik, Bora, & Srivastava, 2002). Whole LS seeds yield a multitude of
nutrients: moisture (4.14 %), protein (22.47 %), fat (27.48 %), carbohydrate (34.24 %) and crude
fiber (7.01 %). The minerals in LS seeds include potassium (1,193.95 mg/100 g), phosphorous
(514.59 mg/100 g), magnesium (315.25 mg/100 g), calcium (296.60 mg/100 g), sulfur (293.02
mg/100 g), sodium (24.64 mg/100 g), iron (7.62 mg/100 g), copper (5.53 mg/100 g), zinc (5.05
mg/100 g), aluminum (2.82 mg/100 g), manganese (2.57 mg/100 g), boron (1.41 mg/100 g) and
molybdenum (0.43 mg/100 g). The non-essential amino acid profile for LS seeds (g/100g
protein) includes aspartic acid (9.76), glutamic acid (19.33), serine (4.96), glycine (5.51), alanine
(4.83), tyrosine (2.69) and proline (5.84). The essential amino acid profile for LS seeds (g/100g
protein) include histidine (2.66), threonine (4.51), arginine (8.04), valine (5.67), methionine
(0.97), phenyl alanine (5.65), isoleucine (5.11), leucine (8.21) and lysine (6.26) (Gokavi,
Malleshi, & Guo, 2004). The antioxidant properties of LS seeds had a 94.18% DPPH inhibition
and a reducing power assay absorbance of 0.749 (Panwar, et al., 2014).
Lepidium sativum and Medicinal Utility
LS has been utilized to treat various human ailments such as seminal weakness, cold,
bronchial asthma (Paranjape & Mehta, 2006), hyperglycemia (Eddouks, Maghrani, Zeggwagh, &
Michel, 2005), osteoarthritis (Raval & Pandya, 2009), fracture healing (Juma, 2007), cough,
dyspepsia, diarrhea (Manohar, et al., 2009), dysentery, leukorrhea, liver disease (Sakran, et al.,
2014), renal diseases, skin, eye diseases and scurvy (Billore, Yelne, Dennis, & Chaudhari, 2005).
It is also considered having antihypertensive effects and acts as a diuretic (Maghrani, Zeggwagh,
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Michel, & Eddouks, 2005), thermogenic, depurative, ophthalmic, tenesmus, secondary syphilis
and leprosy (Manohar, Viswanatha, Nagesh, Vishal, & Shivaprasad, 2012). LS has also been
shown to have a high inhibitory effect against the pathogenic organisms Staphylococcus aureus,
Escherichia coli, Klebsiella pneumonae and Proteus vulgaris. LS acted similar to standard
antibiotics Gentamicin and Ketoconzol when tested for inhibitory effects on Pseudomonas
aeruginosa and Cadida albicans (Adam, Salih, & Abdelgadir, 2011). It has been observed that
2.25% LS seed supplementation in broilers had no adverse effects (Shawle, Urge, & Animut,
2016) and 10% LS seed supplementation was nontoxic in Wistar rats (Datta, et al., 2011).
Another study observed nontoxic effects at 2% LS seed supplementation, toxic effects but
nonfatal at 10% and lethal and depressed growth rate at 50% in albino rats (Adam, 1999).
Lepidium sativum and Reproductive Regulation
To date, there have only been a handful of studies performed investigating the effects of
LS on reproduction. LS seeds have been shown to act as a galactagogue (Kumar, Baghel, &
Khare, 2011), abortifacient (Nath, Sethi, Singh, & Jain, 1992) and contraceptive (Sharief & Gani,
2004) in females. LS has been cited in many articles for anti-ovulatory properties but in one
study with an ethanolic extract of LS seeds there was 0% inhibition of ovulation in rabbits
(Vohora, Khan, & Afaq, 1973). Interestingly, LS seeds in males have been shown to increase
testicular and epididymal sperm concentration (Naji & Abood, 2013a, 2013b) and act as an
aphrodisiac (Mali, Mahajan, & Mehta, 2007). Therefore, contrasting results exist regarding the
use of LS seeds as a reproductive medicinal supplement.
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Hypothalamic Regulation of Reproduction
Reproduction in all mammals is regulated by the hypothalamic-pituitary-gonadal axis.
The highest level of control happens at the hypothalamus. The hypothalamus is part of the
diencephalon that lies below the thalamus. It forms the walls and lower part of the third ventricle
of the brain. The rostral boundary of the hypothalamus is the optic chiasm while on the posterior
end is the mammillary bodies. At the lower part of the third ventricle is the tuber cinereum.
Located on the tuber cinereum is a small swelling known as the median eminence. This structure
is part of the anatomical link between the hypothalamus and anterior pituitary gland. The interior
region of the median eminence is responsible for housing the axonal fibers of neurons
responsible for secreting oxytocin and vasopressin. The external region of the median eminence
is responsible for containing the terminals of hypophysiotropic neurons. The hypophysiotropic
neuron terminals release hypothalamic hormones into the hypophyseal portal system which will
then travel to the anterior pituitary gland. The hypothalamus is responsible for secreting
gonadotropin-releasing hormone (GnRH). GnRH is secreted in either a pulsatile or surge fashion.
Pulsatile secretion is regulated by the arcuate region while surge secretion is regulated by the
pre-optic area. Pulsatile secretion of GnRH is pivotal to maintaining the responsiveness of the
gonadotroph. Constant infusion of GnRH has been shown to lead to a down-regulation of the
processes responsible for gonadotropin release. The mechanism of GnRH pulsatile secretion has
been attributed to intrinsic factors such as autocrine regulation (Karazhiyan, et al., 2009). Within
the hypothalamic GnRH neurons are estrogen receptors alpha and beta. The expression of these
receptors dictate that estrogen may directly modulate GnRH neuronal function. It has been
shown that estrogen receptor beta activation led to increased GnRH secretion, cyclic adenosine
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monophosphaste production, and action potential firing. Interestingly, when estrogen receptor
alpha is activated subsequent activation of G protein-activated inwardly rectifying potassium
channels. These channels then decrease because of the hyperpolarization of the cell membrane
thus decreasing secretion of GnRH (Lüscher & Slesinger, 2010). Once GnRH has been secreted
from the hypothalamus it travels through the hypophyseal portal system towards its target, the
anterior pituitary gland.
The pituitary gland is located in the sella turcica. It is separated into the posterior lobe,
neurohypophysis, and anterior lobe, adenohypophysis. The posterior lobe is consists of neural
tissue while the anterior lobe consists of glandular tissue. The anterior pituitary gland is
responsible for secreting the reproductive hormones luteinizing hormone (LH) and folliclestimulating hormone (FSH) in response to GnRH stimulation. LH and FSH then regulate gonadal
functions: gametogenesis and steroidogenesis. The female gonads consist of the estrogen and
progesterone producing ovaries while the male gonads consist of the testosterone producing
testes. These gonadal steroids have negative feedback loops that act on the hypothalamus, long
loop, or the pituitary gland, short loop. These negative feedback loops help maintain hormonal
homeostasis. Ovaries and testes produce gametes: eggs and sperm, respectively. Eggs and sperm
are created from undifferentiated gonadal cells called germ cells.
Female Reproduction
The ovaries consist of a tough fibrous capsule known as the tunica albuginea. The
innermost layer is known as the medulla which is where the vessels are located. The layer
between the medulla and tunica albuginea is the cortex. The cortex contains an abundance of
ovarian follicles that are at various stages of development. Within each primary follicle contains
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a primary oocyte. Surrounding the primary oocyte are granulosa cells, a basement membrane and
an outer layer of theca cells.
Ovaries are attached to the uterus by the ovarian ligament. There is a small gap between
the ovary and fimbriae connected to the fallopian tube. The fallopian tube then joins with the
uterus. At the base of the uterus connects the cervix and then the vaginal canal. The uterus
consists of three layers: innermost endometrium, middle myometrium and outmost perimetrium.
The female body produces gametes on a monthly cycle known as the menstrual cycle.
The name stems from the 3-7 day bloody uterine discharge known as menses. The menstrual
cycle is divided into two more cycles: the ovarian cycle and uterine cycle. The ovarian cycle is
further divided into three phases: follicular phase, ovulation and luteal phase. The follicular
phase consists of growth of follicles in the ovary which is regulated by FSH. This phase has a
duration ranging from ten days to three weeks. During ovulation one or more follicles have
matured leading to the release of an oocyte which is regulated by a preceding surge in LH. The
surge in LH is produced by a surge of GnRH. One key enzyme involved with the expulsion of
the ovum from the ovulatory follicle is cyclooxygenase 2 (COX-2). The LH surge propagates the
synthesis of prostaglandins in the cumulus cells (Dinchuk, et al., 1995). COX-2 mediates the
synthesis of prostaglandins from arachidonic acid (Ricciotti & FitzGeral, 2011). LH also
modulates the luteal phase transforming the ruptured follicle into the corpus luteum. The corpus
luteum then secretes progesterone that will prepare the uterus for pregnancy. If pregnancy does
not occur after two weeks then the corpus luteum will regress into the corpus albicans and cease
to secrete hormones. The ovarian cycle will then start over.
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The uterine cycle refers to ongoing changes in the endometrial lining of the uterus
regulated by ovarian hormones. The uterine cycle is divided into three phases: the menses phase,
proliferative phase and secretory phase. The menses phase coincides with the beginning of the
ovarian follicular phase. This is marked by the menstrual bleeding that occurs in the uterus. The
proliferative phase occurs towards the end of the ovarian follicular phase. This is marked by an
increase in the number of cells within the endometrium awaiting pregnancy. At the end of the
proliferative phase ovulation occurs. The secretory phase coincides with the ovarian luteal phase.
The hormones secreted from the corpus luteum convert the thick endometrial layer into a
secretory structure. If pregnancy does not occur then the thickened endometrial layer that was
converted to secretory structures are sloughed off during menses.
Female Rodent Reproductive Cycle
Female rodents are polyestrous, which includes Rattus norvegicus. The rats have an
estrous cycle lasting four to five days. The cycle is composed of four phases: proestrus, estrus,
metestrus and diestrus. The first phase, proestrus, is described as when the animal is coming into
heat. The second phase, estrus, is characterized by a female animal’s readiness to receive a male
for coitus. If conception does not take place then the female will move into the next phase,
metestrus. This phase is characterized by the estrus effects subsiding within the reproductive
tract. The next phase is diestrus, comparable to the luteal phase in primates. The cycle will then
repeat back to the proestrus stage. Vaginal smears are the most common way to determine the
phase female rats are in. Proestrus is characterized by a predominance of nucleated epithelial
cells. The estrus phase is characterized by anucleated cornified cells. Metestrus is characterized
by the same proportion of leukocytes, cornified and nucleated epithelial cells. Diestrus is
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characterized by a predominance of leukocytes (Yener, et al., 2007). After diestrus, LH and FSH
levels start to increase from the anterior pituitary gland. FSH triggers expression of LH receptors
in the ovaries while LH will propagate the synthesis and secretion of androstenedione which
leads to the synthesis of estrogen. During proestrus there is an increase in estrogen secretion
which inhibits GnRH release subsequently inhibiting LH and FSH secretion. This inhibition is
also achieved by the secretion of the ovarian hormone inhibin. Estrogen levels peak during
midday of the proestrus phase. This peak is important because the inhibition of GnRH ceases
thus increasing GnRH secretion and LH and FSH responsiveness to GnRH. The effects of
estrogenic modulation here is pivotal to the surge in preovulatory GnRH, LH and FSH levels.
There is however a second FSH surge which is GnRH-independent and occurs during ovulation
or soon after. The second surge in FSH helps to prepare a follicle for the next cycle. During
proestrus, progesterone levels increase and peak during ovulation. After ovulation, LH and FSH
secretion is inhibited by progesterone and estrogen. Progesterone levels also increase with
estrogen during proestrus which stimulates GnRH secretion which reinforces the LH
preovulatory surge. Estrus can be induced in rats by administering estradiol-17β and
progesterone. Once estrus begins, eight to twelve hours later ovulation occurs (Plant, et al.,
2015).
Neural Control during Estrous Cycle
Throughout the estrous cycle the LH secretion pattern is pulsatile. The frequency of these
pulses are less than one pulse per hour. It has been shown that the mechanism for LH secretion is
under a 24 h photoperiodic control. This means it can fall under the category of a circadian
rhythm (Levine & Sawyer, 1950). Studies have shown the paired suprachiasmatic nuclei (SCN)
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of the hypothalamus functions as a generator of the signal that is entrained to the light-dark
rhythm. The SCN is responsible for generating 24 h rhythms. The SCN times the appropriate
initiation of GnRH surge on the afternoon of proestrus. This surge in GnRH subsequently
secretes a surge of LH. The estrous cycle ceases when the SCN is lesioned. As mentioned before,
GnRH pulsatility is pivotal to maintaining responsiveness of the anterior pituitary gland. During
the afternoon of proestrus, the GnRH pulses are interrupted by a surge in the secretion of GnRH.
This surge will propagate the preovulatory surge in gonadotropin hormones. While the SCN
provides daily neuronal signals for the surge secretion of GnRH, the anteroventral periventricular
nucleus receives these signals. Combined with the ovarian hormones, a surge secretion of GnRH
is initiated (Plant, et al., Zeleznik, 2015).
Male Reproduction
The testes consist of a tough fibrous capsule known as the tunica albuginea. Within the
tunica albuginea are an abundance of seminiferous tubules. This is the location where
spermatogenesis takes place. The interstitial tissues around the seminiferous tubules consist of
blood vessels and testosterone producing Leydig cells. Inside the seminiferous tubules the germ
cells or spermatogonia, mature towards the lumen into sperm cells. Sertoli cells regulate sperm
development by secreting proteins to help nourish developing sperm cells. Spermatogonia whose
fate is to become sperm cells mature towards the lumen of seminiferous tubules. The
seminiferous tubule exits the testis and joins the epididymis. The epididymis is a worm like
structure that wraps around the testis consisting of three sections: head, body and tail. The tail of
the epididymis stores mature sperm. The tail then forms into the vas deferens. The vas deferens
then joins into the urethra. Sperm contribute approximately 1% of the volume of semen that is
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ejaculated. The other 99% of the semen volume come from fluid secreted by accessory glands:
bulbourethral glands, seminal vesicles and prostate gland. The bulbourethral glands contribute a
mucus-like fluid utilized for lubrication. The fluid also contains buffers that neutralize the
residual acidic urine in the urethra and the acid environment of the vaginal. The seminal vesicles
contribute prostaglandins and nutrients. The prostaglandins help influence sperm motility and
transport in male and female reproductive tracts. The prostate gland also contributes nutrients
with the seminal vesicles for sperm metabolism.
Metabolism
Metabolism begins with the intake of food. The behavioral mechanism of when to eat
depends on hunger and satiety. These two functions are controlled by the hypothalamus by a
tonically active feeding center and a satiety center that regulates feed intake by inhibiting the
feed center. Peptides that have shown to increase food intake include ghrelin and orexins.
Peptides that have shown to decrease food intake include cholecystokinin, glucagon-like peptide1, peptide YY, corticotropin-releasing hormone, α-melanocyte-stimulating hormone and cocaineand amphetamine-regulated transcript. Food begins to be broken down mechanically and
chemically in the mouth then moves towards the stomach where the food is digested into smaller
molecules via acid secretion. The chyme then moves into the small intestines where acinar cells
from the pancreas further aid in digestion. The acidic chyme is then neutralized by sodium
bicarbonate secreted by duct cells in the pancreatic duct. Bile is then secreted from hepatocytes
concurrent with the pancreatic enzymes and sodium bicarbonate. The bile facilitates enzymatic
fat digestion. The broken down smaller molecules are then absorbed in the intestines. After the
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molecules are absorbed they flow through the hepatic portal vein to the liver. The liver functions
as a filter to remove any potentially harmful xenobiotics before they enter the rest of body.
Apart from aiding in digestion the pancreas plays a key role in maintaining plasma
glucose homeostasis. The pancreas secretes two key hormones: insulin and glucagon. Within the
pancreas are structures called islets of Langerhans that contain beta cells and alpha cells. Beta
cells are responsible for secreting insulin to lower plasma glucose levels by increasing uptake of
glucose in the tissues. Alpha cells are responsible for secreting glucagon to increase plasma
glucose levels by increasing the synthesis of glucose. These hormones are predominately
responsible for plasma glucose homeostasis.
Mammals have two bean shaped kidneys lateral to the abdominal aorta. The functions of
the kidneys are to regulate extracellular fluid volume and blood pressure, osmolarity,
maintenance of ion balance, excretion of wastes and production of hormones. The kidney is
divided into an inner medullary region and an outer cortical region. Within the regions is a vast
network of tubules called nephrons. Each nephron is initiated by a Bowman’s capsule that
surrounds the glomerulus. The Bowman’s capsule is comprised of simple squamous epithelium.
Blood is filtered out of the glomerulus and into the Bowman’s capsule. The filtrate then flows
into the proximal convoluted tubule, distal convoluted tubule, and collecting duct on its way to
the bladder to await excretion.
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Chapter III: Hypotheses
Based on the evidence presented in the literature review section of this thesis, we
hypothesize:
a. females exposed to LS seed extract and P4 will have a lower amplitude GnRH surge
b. females exposed to LS seed extract and P4 will have a lower amplitude LH surge
c. females exposed to LS seed extract and P4 will have a lower amplitude FSH surge
d. males fed rat chow with 15% inclusion of LS seeds will have an increased sperm
density
e. males fed rat chow with 15% inclusion of LS seeds will have an increased
testosterone secretion in perifusate samples from testis parenchyma
f. males fed rat chow with 15% inclusion of LS seeds will have an increased plasma
testosterone level
g. males fed rat chow with 15% inclusion of LS seeds will have histopathological
evidence
h. males fed rat chow with 15% inclusion of LS seeds will have abnormal growth of
their organs.
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Chapter IV: Materials and Methods
The research protocols utilized in this study were approved by the Institutional Animal
Care and Usage Committee of St. Cloud State University, St. Cloud, Minnesota, USA. The
research was conducted in accordance with the National Institute of Health’s Guide for the Care
and Use of Laboratory Animals (2011). All experiments were carried out in the vivarium at St.
Cloud State University, St. Cloud, Minnesota, USA.
Plant Acquisition and Preparation
LS seeds were purchased from a local market in Gombe, Nigeria and confirmed in the
Department of Forestry and Wildlife Management, Federal University of Agriculture, Abeokuta,
Nigeria. The seeds were electrically blended to a fine powder using a single-speed food blender
(Waring Products, Torrington, CT, USA). The LS seed powder (LSSP) was kept in an air tight
container at 4°C until used for animal treatments.
Aqueous Extraction of LS Seeds
LSSP was mixed with deionized water (1 g/100 mL) for 24 h. The solution was filtered
with a vacuum through Whatman qualitative filter paper grade 3 (GE Healthcare Bio-Sciences,
Pittsburgh, PA, USA). The filtrate was then dehydrated in an oven for 48 h. The LS aqueous
extract (LSE) was stored in an air tight container at 4°C.
Experiment 1: Effect of LS Seed Extract on the Surge of GnRH, LH and FSH in
Ovariectomized Female Rats
Our objective of this experiment was to determine the effect of aqueous LSE on the
development and magnitude of the surge releases in GnRH, LH, and FSH that lead to the process
of ovulation in rats. Thirty-two female Sprague-Dawley rats (St. Cloud State University, St.
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Cloud, MN, USA) weighing 200-250 g and between seven and ten weeks of age were used for
this study. Rats were ovariectomized using standard methods and housed in individual plastic
cages. They were maintained under a lighting regime of 12 hours under light and 12 hours in the
dark at 25°C. Rat feed (Global Diets, Madison, WI, USA) and water were provided ad libitum.
The rats were utilized seven to ten days after ovariectomy to allow time to heal. On days 1 to 3 at
1000 h, all rats were injected with estradiol-17β (10 μg/0.2 mL/rat, s.c. in corn oil). On day 4 at
0800 h, sixteen of the rats were treated with LSE (40 mg/Kg BW, i.p.) while the remaining
sixteen received normal saline diluent at the same rate. At 1000 h, eight rats that received LSE
and eight rats that received normal saline were treated with corn oil (0.2 mL/rat, s.c.) while the
remaining sixteen rats, eight that received LSE and eight that received saline, were treated with
progesterone (2.5 mg/0.2 mL/rat, s.c. in corn oil). These regimens of hormonal treatments
produce physiological levels of plasma estradiol-17β and progesterone and consistently generate
preovulatory-like surges of GnRH, LH and FSH. These treatments therefore produce the
following treatment groups: Group 1: OVX+E2+Saline, n=8; Group 2: OVX+E2+LSE, n=8;
Group 3: OVX+P4+Saline, n=8; Group 4: OVX+P4+LSE, n=8. At 1300 h, the rats were
euthanized using an overdose of 6 mL 2.5% tribromoethanol. The hypothalamus was extracted
by removing the brain from the skull. The brain was then inverted exposing the posterior side.
Utilizing a scalpel and number 11blade, a cut was made immediately posterior the optic chiasm.
Another cut was made anterior the mammillary bodies. Two more cuts were made on the ventral
lateral ridges. The hypothalamus was then cut midsagittal to yield two hemi-hypothalamic
fragments. The pituitary gland was extracted from the surface of the sella turcica with a scalpel
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and number 11 blade. The hemi-hypothalamic fragments and pituitary gland from each rat were
then perifused.
Perifusion of Hemi-Hypothalamic Fragments
The hemi-hypothalamic fragments obtained from the above treatment groups were
perifused utilizing a 12-chamber Suprafusion 1000 (Brandel, Gaithersburg, MD, USA) with
artificial cerebrospinal fluid (aCSF) at 37°C for a period of seven hours. The perifusate fractions
were collected at 15-minute intervals yielding a collected volume of 2 mL per fraction. GnRH
concentrations were determined in all perifusates using radioimmunoassays.
Perifusion of Pituitary Gland
Pituitary glands obtained from the above treatment groups were perifused using a 6chamber Suprafusion 1000 (Brandel, Gaithersburg, MD, USA) with aCSF at 37°C for a period of
seven hours. After 60 minutes, 10 ng/mL of GnRH was administered to the pituitary glands for
30 minutes. GnRH was added to assist in surging of LH and FSH because of the severed link
between the hypothalamus and pituitary gland. The perifusate fractions were collected at 15minute intervals yielding a collected volume of 2 mL per fraction. LH and FSH concentrations
were determined in all perifusates using radioimmunoassays.
Radioimmunoassay of GnRH
GnRH concentrations were determined utilizing the technique by Ellinwood et al. (1985).
GnRH (Sigma Aldrich, St. Louis, MO, USA) was iodinated using 125I (Perkin Elmer
Laboratories, Waltham, MA, USA) by the Chloramine-T method. The GnRH standards were 1,
5, 10, 25, 50, 100, 250, 500 and 1,000 pg/mL. The antiserum R1245 (Colorado State University,
Fort Collins, CO, USA) was utilized at 1:12,000 dilution.
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The radioimmunoassay (RIA) for GnRH is a three-day assay. On day 1, standards
(200 μL), perifusate samples (200 μL) in duplicates and antibody (50 μL) were pipetted into
12x75 mm borosilicate glass tubes (VWR International, Radnor, PA, USA). The tubes were then
vortexed briefly and stored at 4°C for 24 h. On day 2, the tracer (125I-GnRH; 11,000 cpm/50 μL)
was pipetted to all tubes, vortexed briefly and then stored at 4°C for 24 h. On day 3, 1.5 mL 95%
ice cold ethanol was pipetted into all tubes as a precipitating agent and then vortexed. The tubes
were then centrifuged at 3,000 rpm at 4°C for 20 minutes using the Sorvall RT7 plus centrifuge
(Thermo Scientific, Waltham, MA, USA). The supernatant was discarded into a waste
receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter
(Perkin Elmer, Waltham, MA, USA).
Radioimmunoassay of LH
LH concentrations were determined utilizing the techniques described by Bernard et al.
(1983). LH was iodinated using 125I (Perkin Elmer Laboratories, Waltham, MA, USA) by the
Chloramine-T method. The LH (National Institute of Diabetes and Digestive and Kidney
Diseases, Bethesda, MD, USA) standards that were used include 0.8, 1.6, 3.1, 6.2, 12.5, 25 and
50 ng/mL. The first antiserum AFP 240580 was utilized at 1:40,000 dilution. The second
antibody that was used is goat anti-rabbit immunoglobulin G (GARGG, Equitech-Bio, Inc,
Kerrville, TX, USA) at a dilution of 1:1 with 0.01 M phosphate buffered saline (PBS) and
EDTA.
Briefly on day 1, standards (200 μL), perifusate samples (100 μL) in duplicates, first
antibody (100 μL) and tracer (125I-LH; 20,000 cpm/100 μL) were pipetted into 12x75 mm
borosilicate glass tubes (VWR International, Radnor, PA, USA). The tubes were then vortexed
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briefly before being stored at 4°C for 48 h. On day 3, the second antibody GARGG (200 μL) was
pipetted into the tubes along with 6% polyethylene glycol (500 μL). Afterwards, the tubes were
vortexed briefly and centrifuged at 3,000 rpm at 4°C for 15 minutes using the Sorvall RT7 plus
centrifuge (Thermo Scientific, Waltham, MA, USA). The supernatant were discarded into a
waste receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter
(Perkin Elmer, Waltham, MA, USA).
Radioimmunoassay of FSH
FSH concentration was determined utilizing techniques described by Odell et al. (1968).
FSH was iodinated using 125I (Perkin Elmer Laboratories, Waltham, MA, USA) by the
chloramine-T method. The FSH (National Institute of Diabetes and Digestive and Kidney
Diseases, Bethesda, MD, USA) standards that were used include 0.125, 0.25, 0.5, 1.5, 2.5, 5.0,
10.0, 20.0 and 50 ng/mL. The first antiserum AFP C528813 was utilized at 1:15,000 dilution.
The second antibody that was used is GARGG (Equitech-Bio, Inc, Kerrville, TX, USA) at a
dilution of 1:1 with 0.01 M PBS and EDTA.
The RIA for FSH is a 5-day assay. On day 1, standards (200 μL), perifusate samples (200
μL) in duplicates and first antibody (200 μL) were pipetted into 12x75 mm borosilicate glass
tubes (VWR International, Radnor, PA, USA). The tubes were then vortexed briefly before being
stored at 4°C for 24 h. On day 2, the tracer (125I-FSH; 20,000 cpm/100 μL) were pipetted into all
tubes, vortexed briefly, and then stored at 4°C for 60 minutes using a Sorvall RT7 plus
centrifuge (Thermo Scientific, Waltham, MA, USA). The supernatant was discarded into a waste
receptacle. The tubes were then loaded and counted in a Packard Cobra II gamma counter
(Perkin Elmer, Waltham, MA, USA).
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Experiment 2: Effect of LS Seed Inclusion on Reproductive Hormones, Sperm
Concentration, Metabolic and Growth Indices in Male Rats
The objective of this experiment was to determine the acute and chronic effects of 15%
LS seed supplementation on gross organ morphology and histomorphometric indices,
testosterone secretion and spermatogenesis involved in metabolic and spermatogenic functions in
the Sprague-Dawley rat.
LS Experimental Diet
Normal rat chow (Global Diets, Madison, WI, USA) was electrically blended using a
single-speed food blender (Waring Products, Torrington, CT, USA) to a fine powder. The 15%
LS experimental feed was produced by mixing 17 g of finely ground normal rat chow and 3 g of
LSSP with 10 mL deionized water. The mixture was then pelleted by hand into six pellets. The
pellets air-dried for 24-48 h before they were utilized as feed.
Experimental Animals
Forty-eight mature male Sprague-Dawley rats (Charles River Laboratories, Wilmington,
MA, USA) weighing 250-350 g and between seven and ten weeks of age were used for this
study. Rats were housed in individual plastic cages for two weeks prior to the experiment for
acclimation. The rats were maintained under a lighting regime of 12 hours under light and 12
hours in the dark at 25°C. During the acclimation period rat feed and water were provided ad
libitum.
After the acclimation period, each rat was weighed and assigned to either a control group
(0% LS seed inclusion; n=24) or a treatment group (15% LS seed inclusion; n=24). The length of
the study was eight weeks. This duration is important to enable us to determine the acute and
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then chronic effects of feeding these seeds on metabolism and reproduction. Secondly, the 56day study included a period of 48 to 52 days, the duration of one spermatogenic cycle in the rat
(Hafez, 1970). At 0800 h daily, rats were offered either normal rat chow or the 15% LS seed
included rat chow for 8 weeks. At 2, 4, 6 and 8 weeks, six rats from each the Control or the
Treatment groups were euthanized with carbon dioxide asphyxiation for a minimum of 10minutes. All rats were weighed on the first day of the experiment, every other day and
immediately after euthanization to determine bodyweight changes. Every day feed intake and
refusal was measured. Immediately post euthanization, trunk blood was collected for hormone
assays. Further, the paired testes, epididymides, prostate gland, seminal vesicles, kidneys,
adrenal glands, heart, liver, spleen, lungs, brain and pancreas were harvested and weighed. The
relative organ weights were normalized to organ weight per 100 g BW. One kidney and one
testis were preserved in 10% formalin buffer for histological analysis. The other testes were
utilized for in vitro testosterone production determination. One cauda epididymis per rat was
isolated and utilized for the epididymal sperm count.
Kidney Histological Analysis
The kidneys obtained for histological analysis were stored in 10% formalin until fixated
in paraffin wax. Each kidney was sectioned at 5 μm superficially and then 100 μm deep. The
tissue was then stained in Hematoxylin and Eosin. Pictures were taken of the Bowman’s capsule,
glomerulus, proximal tubule and distal tubule utilizing a light microscope DM750 (Leica,
Buffalo Grove, IL, USA) with an attached camera. The diameters of the aforementioned
structures were measured using ImageJ (National Institute of Health, Bethesda, MD, USA).
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Within each structure evidence of disease presence was graded as 1, disease present, or 0, disease
absent. The disease presence is presented as a percentage.
Testes Histological Analysis
The testes obtained for histological analysis were stored in 10% formalin until fixated in
paraffin wax. Each testis was sectioned at 5 μm superficially and then 100 μm deep. The tissue
was then stained in Hematoxylin and Eosin. Pictures were taken of the seminiferous tubules,
germinal cell layer and Leydig cells utilizing a light microscope DM750 (Leica, Buffalo Grove,
IL, USA) with an attached camera. The diameters of the seminiferous tubules, thickness of
germinal cell layer and diameter of Leydig cells were measured using ImageJ (National Institute
of Health, Bethesda, MD, USA).
In Vitro Testosterone Production
Two 100 mg samples (A and B) of parenchyma from each testis were loaded into
Suprafusion 1000 equipment (Brandel, Gaithersburg, MD, USA). The parenchyma was perifused
for three hours collecting 4 mL of perifusate at 30 minute increments at a constant temperature of
37°C. During the first hour, all samples were perifused in 0.01 M phosphate buffered saline
(PBS). During the second and third hours, sample A was perifused in 0.01 M PBS while sample
B was perifused in 150 mIU/mL human chorionic gonadotropin (hCG) in 0.01 M PBS. The
hormone hCG was utilized because of its stimulatory effect of testosterone secretion similar to
luteinizing hormone. Perifusate fractions were stored at -80°C until assayed utilizing a double
antibody testosterone 125I radioimmunoassay kit for testosterone (MP Biomedicals, Costa Mesa,
CA, USA).
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Epididymal Sperm Density
The cauda epididymis was isolated by cutting approximately 1 mm down from the
junction of the vas deferens and the cauda epididymis and also at the junction of corpus
epididymis and cauda epididymis. The cauda epididymis weight was then obtained. The
epididymal sperm concentrations were obtained using a Neubauer hemocytometer as described
by Wang (2003). The sperm density was calculated as total number of sperm per cauda / cauda
weight (mg).
Statistical Approach
Statistical analysis utilized the statistical software SPSS 24 (IBM, Armonk, NY, USA).
The main effect of dose and time and their interactions on GnRH, LH and FSH secretions were
determined using the multivariate analysis of variance (MANOVA) in experiment 1. Experiment
2 utilized a MANOVA to analyze the effect of the treatment of the seeds and the effect of time of
feeding for the various aforementioned measurement variables (body weights, feed intake, organ
weights, testosterone secretions, plasma testosterone, sperm concentration and various
histological parameters: Bowman’s capsule diameter, glomerular diameter, proximal and distal
tubule diameter, disease presence, seminiferous tubule diameter, germinal cell layer thickness
and Leydig cell diameter).
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Chapter V: Results
Experiment 1
The profile of GnRH in hemi-hypothalamic fragments obtained from all treatment groups
are shown in Figures 1-3. Ovariectomized, estrogen primed, progesterone treated rats showed
increased GnRH secretion behavior at 180 and 240 minutes after progesterone administration.
Although not statistically significant, this secretion corresponded to the afternoon and is
indicative of a surge-like secretion. LSE treatment at 40 mg/Kg BW seemed to cause this surgelike secretion to occur earlier, around 40 and 90 minutes, in the progesterone-treated rats and the
magnitude of the surge was also attenuated. Although pulsatile, no surge-like GnRH secretion
was observed in either saline or LSE treated ovariectomized, estrogen-primed hemihypothalamic fragments.
Overall, average GnRH secretion was significantly greater in progesterone-treated,
estrogen-primed rats compared to saline-treated, estrogen-primed rats (Figure 1). The total
GnRH secretion for estrogen-primed, progesterone and saline-treated, ovariectomized rats was
96.5 pg/mL (Table 1). The estrogen-primed, progesterone and LSE-treated, ovariectomized rats
was slightly increased at 98.9 pg/mL, but not significant. The estrogen-primed, saline-treated,
ovariectomized rats had similar GnRH secretions of 92.5 pg/mL. Rats that were estrogen-primed,
LSE-treated, ovariectomized had nonsignificant decreased total GnRH secretions of 74.3 pg/mL.
Averaged over time, perifusate LH secretion was significantly greater (p<0.05) in
ovariectomized, estrogen-treated rats compared to ovariectomized, estrogen-primed,
progesterone treated rats. LSE treatment had no effect on LH secretion in either the estrogen or
progesterone-treated rats (Figure 6).
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Temporally, LH secretion from the pituitary gland in all treatment groups decreased over
time. Perifusate LH level was high varying from 15-36 ng/mL pre-GnRH administration (Figures
4 & 5). Administration of GnRH of 10 ng/mL had no stimulatory effect on LH secretion in any
treatment group. Consequently, no surge-like LH secretion was observed. Total LH secretions
were similar among the ovariectomized, estrogen-primed, progesterone and saline or LSE treated
rats, 209.4 and 208.1 ng/mL, respectively (Table 1). Ovariectomized, estrogen-primed, saline or
LSE treated rats had similar total LH secretions of 297.4 and 301.2 ng/mL, respectively.
The profile of FSH in perifusates obtained from all experimental groups are shown in
Figures 7-9. Overall, FSH decreased from time 0 to about 180 minutes and then stabilized.
Average perifusate FSH levels were significantly higher in ovariectomized, estrogen-primed,
progesterone-treated rats compared to ovariectomized, estrogen-primed rats. LSE administration
significantly increased (p<0.05) average perifusate FSH secretion in the ovariectomized,
estrogen-primed rats but had no effect in the ovariectomized, estrogen-primed, progesteronetreated rats. Administration of GnRH at 10 ng/mL had no effect in perifusate FSH secretion.
Total FSH secretion for ovariectomized, estrogen-primed, progesterone-treated rats were similar
to ovariectomized, estrogen-primed, LSE-treated rats, 21.4 and 24.2 ng/mL, respectively (Table
1). The ovariectomized, estrogen-primed rats had a nonsignificant decrease in total FSH
secretion, 17.0 ng/mL, compared to ovariectomized, estrogen-primed, LSE-treated rats, 35.7
ng/mL.
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Figure 1. Perifusion of hemi-hypothalamic fragments from ovariectomized female SpragueDawley rats for gonadotropin releasing hormone. Control groups receiving corn oil + saline, corn
oil + LSE and progesterone + saline: yellow square, green triangle and purple circle,
respectively. Experimental group receiving progesterone + LSE, orange diamond.
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Figure 2. Perifusion of hemi-hypothalamic fragments from ovariectomized female SpragueDawley rats for gonadotropin releasing hormone by period. Control groups receiving corn oil +
saline, corn oil + LSE and progesterone + saline: yellow square, green triangle and purple circle,
respectively. Experimental group receiving progesterone + LSE, orange diamond.
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Figure 3. Perifusion of hemi-hypothalamic fragments from ovariectomized female SpragueDawley rats for average gonadotropin releasing hormone secretion. Control groups receiving
corn oil + saline, corn oil + LSE and progesterone + saline: yellow solid, green vertical stripes
and purple horizontal stripes, respectively. Experimental group receiving progesterone + LSE,
orange diagonal stripes. * indicates significantly different at p<0.05.
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Figure 4. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for luteinizing hormone. Control groups receiving corn oil + saline, corn oil + LSE and
progesterone + saline: yellow square, green triangle and purple circle, respectively. Experimental
group receiving progesterone + LSE, orange diamond.
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Figure 5. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for luteinizing hormone by period. Control groups receiving corn oil + saline, corn oil + LSE
and progesterone + saline: yellow square, green triangle and purple circle, respectively.
Experimental group receiving progesterone + LSE, orange diamond.
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Figure 6. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for average luteinizing hormone secretion. Control groups receiving corn oil + saline, corn
oil + LSE and progesterone + saline: yellow solid, green vertical stripes and purple horizontal
stripes, respectively. Experimental group receiving progesterone + LSE, orange diagonal stripes.
* indicates significantly different at p<0.05.
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Figure 7. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for follicle-stimulating hormone. Control groups receiving corn oil + saline, corn oil + LSE
and progesterone + saline: yellow square, green triangle and purple circle, respectively.
Experimental group receiving progesterone + LSE, orange diamond.
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Figure 8. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for follicle-stimulating hormone by period. Control groups receiving corn oil + saline, corn
oil + LSE and progesterone + saline: yellow square, green triangle and purple circle,
respectively. Experimental group receiving progesterone + LSE, orange diamond.
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Figure 9. Perifusion of pituitary gland fragments from ovariectomized female Sprague-Dawley
rats for average follicle-stimulating hormone secretion. Control groups receiving corn oil +
saline, corn oil + LSE and progesterone + saline: yellow solid, green vertical stripes and purple
horizontal stripes, respectively. Experimental group receiving progesterone + LSE, orange
diagonal stripes. * indicates significantly different at p<0.05.

50

Table 1. Effect of aqueous LS extract on total hormonal secretion of
GnRH, LH and FSH from the hypothalamus and pituitary gland for 7 hours
Total Hormone Secretion
Group
GnRH (pg/mL)
LH (ng/mL)
FSH (ng/mL)
OVX+E₂ +Saline 92.5 ± 2.36
297.4 ± 21.85
17.0 ± 2.01
OVX+E₂ +LSE
74.3 ± 2.10
301.2 ± 42.18
35.7 ± 2.25
OVX+P₄ +Saline 96.5 ± 3.56
209.4 ± 20.44
21.4 ± 1.89
OVX+P₄ +LSE
98.9 ± 3.59
208.1 ± 22.08
24.2 ± 1.90
Values are mean ± S.E.M. of 29 female Sprague-Dawley rats. No
significance was observed.
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Experiment 2
Over the duration of the experiment rats fed 0% LS seed supplementation increased in
body weight. During the first week of the experiment, rats fed 15% LS seed supplementation
decreased in body weight (Figure 10) due to the strong feed aversion (Figure 11). During the rest
of the experiment the treatment group gained weight at a rate concurrent with the control group.
The control group had a slight feed aversion but remained steady during the rest of the
experiment. Rats fed 15% LS seed inclusion had a significantly strong feed aversion during the
first few days of the experiment. Afterwards rats in both groups ate approximately the same
amount of feed each day (Figure 11).
Visceral Organ Weights
There were no significantly different paired testicular weight differences throughout the
experiment. Although, there was a non-significant increase in paired testicular weights in rats fed
15% LS seed inclusion during weeks four (Control: 0.840g, Treatment: 0.933 g) and six
(Control: 0.862 g, Treatment: 0.940 g). Week two and eight paired testicular weights were
similar (Figure 12). The epididymides weight differences were not significant (Figure 13). There
was a significant decrease in the treatment groups prostate gland weight during weeks two
(Control: 0.240 g, Treatment: 0.190 g) and six (Control: 0.220 g, Treatment: 0.190 g). There was
however a nonsignificant decrease during weeks four (Control: 0.224 g, Treatment: 0.197 g) and
eight (Control: 0.220 g, Treatment: 0.200 g) (Figure 14). There were no significant weight
changes for the seminal vesicles weight (Figure 15). Interestingly, the control group had a
significantly lower renal weight than the treatment group at each biological endpoint (Figure 16).
During weeks two, four, six and eight the control group renal weights were 0.688, 0.628, 0.670
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and 0.661 g, respectively. During weeks two, four, six and eight the treatment group renal
weights were 0.749, 0.831, 0.810 and 0.890 g, respectively. There were no significant weight
changes for the adrenals, heart, liver, spleen and lungs (Figure 17-21). The control group brain
weight decreased during the experiment at each biological time point. There was a nonsignificant
weight increase for the treatment group during week two (Control: 0.480 g, Treatment: 0.497 g).
During weeks four (Control: 0.459 g, Treatment: 0.528 g), six (Control: 0.452 g, Treatment:
0.489 g) and eight (Control: 0.451 g, Treatment: 0.491g) the brain weight increased significantly
(Figure 22). The pancreatic weight for the control group decreased over the duration of the
experiment (Figure 23). Weeks two, four and six had similar pancreatic weights. The pancreatic
weight during week eight was significantly increased in the treatment group (Control: 0.077 g,
Treatment: 0.104 g).
Renal Histology
Dietary supplementation of LS seeds for eight weeks induced significant signs of toxicity
(Tables 2 & 3). There was a trend of increasing toxicity as the experiment proceeded. The
Bowman’s capsule diameter was not significant except in week eight (Control: 0.164 mm,
Treatment: 0.186 mm). The diameter of the glomerulus was significantly decreased in week four
(Control: 0.158 mm, Treatment: 0.147 mm) and significantly increased in week eight (Control:
0.145 mm, Treatment: 0.155 mm). There was a significant increase in the difference in
Bowman’s capsule and glomerulus in week eight (Control: 0.0194 mm, Treatment: 0.0311 mm).
Renal histopathological analysis yielded significant increase in presence of glomerulosclerosis
(Control Total Average: 34.6%, Treatment Total Average: 65.0%), metaplasia (Control Total
Average: 32.9%, Treatment Total Average: 74.6%) and hyperplasia (Control Total Average:
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39.8%, Treatment Total Average: 79.4%) in the treatment group’s renal corpuscle. Renal
Bowman’s capsule and glomeruli for rats that received 0% LS seed inclusion and 15% with
glomerulosclerosis, metaplasia and/or hyperplasia are depicted in Figure 24 for weeks two and
four. Renal Bowman’s capsule and glomeruli for rats that receive 0% LS seed inclusion and 15%
with glomerulosclerosis, metaplasia and/or hyperplasia are depicted in Figure 25 for weeks six
and eight.
The kidneys displayed abnormal proximal and distal convoluted tubule diameter and
presence of tubule degeneration (Table 4). The proximal convoluted tubule diameter was
significantly larger in week eight for rats receiving 15% LS seed inclusion (Control: 0.0482 mm,
Treatment: 0.0561 mm). There was significantly increased presence of proximal convoluted
tubule degeneration throughout the eight week experimental period. During weeks two, four, six
and eight the proximal tubule degeneration presence was low in the control group at 0.0, 2.5, 2.5
and 0.0%, respectively. During weeks two, four, six and eight the proximal tubule degeneration
presence was high in the treatment group at 35.0, 60.0, 47.5 and 62.5%, respectively. The distal
convoluted tubule diameter was significantly larger in week eight for rats receiving 15% LS seed
inclusion (Control: 0.0396 mm, Treatment: 0.0507 mm). There was significantly increased
presence of distal convoluted tubule degeneration throughout the eight week experimental
period. During weeks two, four, six and eight the distal tubule degeneration presence was low in
the control group at 10.0, 20.0, 10.0 and 15.0%, respectively. During weeks two, four, six and
eight the distal tubule degeneration presence was remarkably high at 77.5, 70.0, 85.0 and 87.5%,
respectively. Renal proximal tubules for rats that received 0% LS seed inclusion and 15% with
tubular degeneration are depicted in Figure 26 for weeks two and four and Figure 27 for weeks
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six and eight. Renal distal tubules for rats that received 0% LS seed inclusion and 15% with
tubular degeneration are depicted in Figure 28 for weeks two and four and Figure 29 for weeks
six and eight.
Testis Histology
The testes displayed no significant change in seminiferous tubule diameter or germinal
cell layer thickness throughout the duration of the experiment. There was a significant increase
in Leydig cell diameter during week two (Control: 0.0123 mm, Treatment: 0.0134 mm) but
throughout the rest of the duration of the experiment the diameters were similar (Table 5).
In Vitro Testosterone Synthesis
The testosterone synthesis of the testis parenchyma was not significant throughout the
experiment (Figure 30). Challenging testis parenchyma with hCG did not increase testosterone
secretion. During week two there was an increase in testosterone secretion for the control group
perifused with 0.01 M PBS 90 minutes into the perifusion at 0.2 ng/mL while the treatment
group perifused with 0.01 M PBS, control and treatment group perifused with 0.01 M PBS +
hCG remained at 0.1 ng/mL (Figure 30A). There was a trend of 0.1 ng/mL of testosterone
secretion. During week four there was a decreasing trend in all groups for the first 120 minutes.
The control group perifused with 0.01 M PBS had the lowest testosterone secretions followed by
the control group perifused with 0.01 M PBS + hCG. Interestingly, the highest testosterone
secretion came from the treatment group perifused with 0.01 M PBS followed by the treatment
group perifused with 0.01 M PBS + hCG (Figure 30B). During week eight there was a
decreasing tend in testosterone secretion for the first 90 minutes. The control group perifused
with 0.01 M PBS had the lowest testosterone secretion at the start of the perifusion. The second
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lowest testosterone secretion was the control group perifused with 0.01 M PBS + hCG in the
beginning. The highest testosterone secretion in the beginning of the perifusion was the treatment
group perifused with 0.01 M PBS + hCG followed by the treatment group perifused with 0.01 M
PBS. At 60 minutes the testosterone secretions began to have similar testosterone secretions.
After 90 minutes each of the groups secreted approximately 0.1 ng/mL of testosterone (Figure
30C).
Plasma Testosterone
The plasma testosterone level fluctuations were not significant throughout the experiment
(Figure 31). The control group increased from week two to week six before decreasing at week
eight. The treatment group increased from week two to week four. The plasma testosterone
levels then decreased during week six and increased at week eight. At week two the control
group plasma testosterone levels were higher at 0.6 ng/mL compared to the treatment group at
0.3 ng/mL. At week four the control group plasma testosterone levels were lower at 0.7 ng/mL
compared to the treatment group at 1.1 ng/mL. At week six the control group plasma testosterone
levels were higher at 0.9 ng/mL compared to the treatment group at 0.4 ng/mL. At week eight the
control group plasma testosterone levels were lower at 0.4 ng/mL compared to the treatment
group at 0.5 ng/mL.
Epididymal Sperm Density
Epididymal sperm densities were not significantly different (Figure 32). There was a
trending increase in both groups over the duration of the experiment concurrently. During week
two the control group had a slightly lower sperm density of 8.2 million sperm/mg Cauda while
the treatment group had a sperm density of 9.3 million sperm/mg Cauda. During week four the
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control group had a slightly lower sperm density of 12.4 million sperm/mg Cauda while the
treatment group had a sperm density of 12.7 million sperm/mg Cauda. During week six the
control group had a slightly increased sperm density of 20.2 million sperm/mg Cauda while the
treatment group had a sperm density of 19.4 million sperm/mg Cauda. During week eight the
control group had an increased sperm density of 32.9 million sperm/mg Cauda while the
treatment group had a sperm density of 30.3 million sperm/mg Cauda.
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Figure 10. Body weights of Sprague-Dawley rats measured every other day after receiving rat
chow with 0% LS seed inclusion (Control; green diamond) and 15% LS seed inclusion
(Treatment; orange square).
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Figure 11. Feed intake of Sprague-Dawley rats measured every day after receiving rat chow
with 0% LS seed inclusion (Control; green diamond) and 15% LS seed inclusion (Treatment;
orange square).
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Figure 12. Paired testicular weight (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 13. Paired epididymides weight (g/100 g BW) measured at each biological time point
after receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed
inclusion (Treatment; orange diagonal stripes).
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Figure 14. Prostate gland weight (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to
the control group.
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Figure 15. Seminal vesicles weight (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 16. Kidney weights (g/100 g BW) measured at each biological time point after receiving
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to
the control group.
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Figure 17. Adrenal gland weights (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 18. Heart weights (g/100 g BW) measured at each biological time point after receiving
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 19. Liver weights (g/100 g BW) measured at each biological time point after receiving
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 20. Spleen weights (g/100 g BW) measured at each biological time point after receiving
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 21. Paired lung weights (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes).
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Figure 22. Brain weights (g/100 g BW) measured at each biological time point after receiving
rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to
the control group.

70

Pancreas Weight (g/100g BW)

0.25
0.2
0.15

*
0.1

Control
Treatment

0.05
0
Week 2

Week 4

Week 6

Week 8

Figure 23. Pancreatic weights (g/100 g BW) measured at each biological time point after
receiving rat chow with 0% LS seed inclusion (Control; green solid) and 15% LS seed inclusion
(Treatment; orange diagonal stripes). * indicates significantly different at p<0.05 compared to
the control group.
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Table 2. Effect of dietary supplementation of LS seeds on relative Bowman’s capsule diameter, glomerular diameter and
difference in Bowman’s capsule and glomerulus diameter

Bowman's Capsule Diameter (mm)

Glomerulus Diameter (mm)

Δ Bowman's Capsule and Glomerulus
(mm)

Week

Control

Treatment

Control

Treatment

Control

Treatment

2

0.159 ± 0.0003

0.154 ± 0.0003

0.138 ± 0.0002

0.131 ± 0.0002

0.0210 ± 0.0001

0.0225 ± 0.0001

4

0.182 ± 0.0002

0.174 ± 0.0002

0.158 ± 0.0002

0.147 ± 0.0002 *

0.0238 ± 0.0001

0.0264 ± 0.0001

6

0.182 ± 0.0002

0.177 ± 0.0002

0.156 ± 0.0002

0.149 ± 0.0002

0.0260 ± 0.0001

0.0285 ± 0.0001

8

0.164 ± 0.0003

0.186 ± 0.0002 *

0.145 ± 0.0002

0.155 ± 0.0002 *

0.0194 ± 0.0001

0.0311 ± 0.0001 *

Values are mean ± S.E.M. of 48 male Sprague-Dawley rats. * indicates significantly different at p<0.05 compared to the
control group
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Table 3. Effect of dietary supplementation of LS seeds on disease presence of glomerulosclerosis, metaplasia and
hyperplasia

Glomerulosclerosis Presence (%)

Metaplasia Presence (%)

Hyperplasia Presence (%)

Week

Control

Treatment

Control

Treatment

Control

Treatment

2

27.62 ± 0.428

49.17 ± 0.418 *

29.52 ± 0.437

53.33 ± 0.417 *

44.76 ± 0.476

61.67 ± 0.407

4

43.33 ± 0.415

69.17 ± 0.386 *

38.33 ± 0.407

86.67 ± 0.284 *

46.67 ± 0.417

85.00 ± 0.299 *

6

39.13 ± 0.426

66.67 ± 0.394 *

25.22 ± 0.379

75.83 ± 0.358 *

46.96 ± 0.436

89.17 ± 0.260 *

8

28.33 ± 0.377

75.00 ± 0.362 *

38.33 ± 0.407

82.50 ± 0.318 *

20.83 ± 0.340

81.67 ± 0.324 *

Values are mean ± S.E.M. of 48 male Sprague-Dawley rats. * indicates significantly different at p<0.05 compared to the
control group
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Figure 24. Renal Bowman’s capsule and glomerulus from rats receiving A. 0% LS seed
inclusion week 2 B. 15% LS seed inclusion week 2 C. 0% LS seed inclusion week 4 D. 15% LS
seed inclusion week 4. H&E X 40.
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Figure 25. Renal Bowman’s capsule and glomerulus from rats receiving A. 0% LS seed
inclusion week 6 B. 15% LS seed inclusion week 6 C. 0% LS seed inclusion week 8 D. 15% LS
seed inclusion week 8. H&E X 40.
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Table 4. Effect of dietary supplementation of LS seeds on proximal tubule diameter, proximal tubule degeneration, distal tubule
diameter and distal tubule degeneration
Proximal Tubule Diameter (mm)

Proximal Tubule Degeneration Presence
(%)

Distal Tubule Diameter (mm)

Distal Tubule Degeneration
Presence (%)

Week

Control

Treatment

Control

Treatment

Control

Treatment

Control

Treatment

2

0.0496 ± 0.000218

0.0441 ± 0.000233

0.00 ± 0.000

35.00 ± 1.21 *

0.0458 ± 0.000193

0.0403 ± 0.000284

10.00 ± 0.760

77.50 ± 1.06 *

4

0.0561 ± 0.000249

0.0559 ± 0.000212

2.50 ± 0.395

60.00 ± 1.24 *

0.0464 ± 0.000267

0.0451 ± 0.000241

20.00 ± 1.01

70.00 ± 1.16 *

6

0.0542 ± 0.000261

0.0509 ± 0.000227

2.50 ± 0.395

47.50 ± 1.26 *

0.0476 ± 0.000287

0.0414 ± 0.000171

10.00 ± 0.760

85.00 ± 0.904 *

8

0.0482 ± 0.000305

0.0561 ± 0.000227 *

0.00 ± 0.000

62.50 ± 1.23 *

0.0396 ± 0.000211

0.0507 ± 0.000309 *

15.00 ± 0.904

87.50 ± 0.837 *

Values are mean ± S.E.M. of 48 male Sprague-Dawley rats. * indicates significantly different at p<0.05 compared to the control group
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Figure 26. Renal proximal tubules rats receiving A. 0% LS seed inclusion week 2 B. 15% LS
seed inclusion week 2 C. 0% LS seed inclusion week 4 D. 15% LS seed inclusion week 4. H&E
X 40.
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Figure 27. Renal proximal tubules rats receiving A. 0% LS seed inclusion week 6 B. 15% LS
seed inclusion week 6 C. 0% LS seed inclusion week 8 D. 15% LS seed inclusion week 8. H&E
X 40.

78

A

B

C

D

Figure 28. Renal distal tubules rats receiving A. 0% LS seed inclusion week 2 B. 15% LS seed
inclusion week 2 C. 0% LS seed inclusion week 4 D. 15% LS seed inclusion week 4. H&E X 40.
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Figure 29. Renal distal tubules rats receiving A. 0% LS seed inclusion week 6 B. 15% LS seed
inclusion week 6 C. 0% LS seed inclusion week 8 D. 15% LS seed inclusion week 8. H&E X 40.
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Table 5. Effect of dietary supplementation of LS seeds on seminiferous tubule diameter, germinal cell
layer thickness and Leydig cell diameter
Seminiferous Tubules (mm)

Germinal Cell Layer Thickness (mm)

Leydig Cell Diameter (mm)

Week

Control

Treatment

Control

Treatment

Control

Treatment

2

0.300 ± 0.0004

0.306 ± 0.0004

0.0573 ± 0.0001

0.0548 ± 0.0001

0.0123 ± 0.00001

0.0134 ± 0.00001 *

4

0.362 ± 0.0003

0.363 ± 0.0003

0.0638 ± 0.0001

0.0596 ± 0.0001

0.0139 ± 0.00001

0.0139 ± 0.00001

6

0.343 ± 0.0003

0.355 ± 0.0003

0.0629 ± 0.0001

0.0600 ± 0.0001

0.0126 ± 0.00001

0.0130 ± 0.00001

8
0.322 ± 0.0004 0.329 ± 0.0003
0.0562 ± 0.0001
0.0581 ± 0.0001
0.0125 ± 0.00001
0.0124 ± 0.00001
Values are mean ± S.E.M. of 48 male Sprague-Dawley rats. * indicates significantly different at p<0.05 compared to the control
group
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Figure 30. Perifusion of testis parenchyma from male Sprague-Dawley rats for testosterone.
Control groups perifused with 0.01 M PBS (red square) and 0.01 M PBS + hCG (green triangle)
while treatment groups were perifused with 0.01 M PBS (purple x) and 0.01 M PBS + hCG (blue
diamond) at each biological time point: A.) Week 2, B.) Week 4 and C.) Week 8.
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Figure 31. Plasma testosterone from male Sprague-Dawley rats measured at each biological
time point after receiving rat chow at 0% LS seed inclusion (Control; green diamond) and 15%
LS seed inclusion (Treatment; orange square).

Millions

Sperm Density (# sperm/ mg Cauda)

83

35

30
25
20
Treatment

15

Control

10
5
0
2

4

6

8

Week
Figure 32. Sperm density from male Sprague-Dawley rats measured at each biological time
point after receiving rat chow at 0% LS seed inclusion (Control; green diamond) and 15% LS
seed inclusion (Treatment; orange square).
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Chapter VI: Discussion
Our overall goals in these studies were first to determine the effect of LS seed
consumption, both in the acute and chronic states, on the endocrinology of ovulation, secondly
on the development of visceral organs and finally on the indices of spermatogenesis in the male
rat model. We have demonstrated that a preovulatory surge-like GnRH secretion is inducible in
vitro in the ovariectomized, estrogen-primed, progesterone treated rats. Our results indicated that
LS supplementation tended to cause an earlier, attenuated preovulatory surge-like GnRH
secretion.
Temporally, LH secretion from the pituitary gland in all treatment groups decreased over
time. Perifusate LH levels were high varying from 15 to 36 ng/mL pre-GnRH administration. We
observed no stimulatory effect of 10 ng/mL GnRH administration. Consequently, no surge-like
LH secretion was observed. Future studies should investigate the use of a higher concentration of
GnRH to stimulate the surge of LH. There was however a suppressive effect of progesterone in
progesterone treated rats on average LH secretion.
Overall, FSH decreased from time 0 to about 180 minutes before stabilizing. Average
FSH levels were significantly higher in ovariectomized, estrogen-primed, progesterone-treated
rats compared to ovariectomized, estrogen-primed rats. LSE administration significantly
increased average FSH secretion in ovariectomized, estrogen-primed rats but had no effect in the
ovariectomized, estrogen-primed, progesterone-treated rats. Administration of GnRH at 10
ng/mL had no effect of FSH secretion. Future studies should investigate the use of a higher
concentration of GnRH to stimulate the surge of FSH. There may be differential regulation of
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FSH secretion because of the increased average FSH secretion observed in the ovariectomized,
estrogen-primed, LSE treated rats.
The observed earlier and attenuated surge-like secretion of GnRH is in line with Sharief
et al. (2004) who observed LS seeds to have contraceptive properties in 100% of mice treated
with one g/day administration of LS seeds orally. LS seeds utilized as an aqueous extract have
also been shown to act as an abortifacient with unknown mechanisms (Nath, et al., 1992).
Interestingly, 200 mg/Kg of ethanolic extract of LS seeds showed 0% inhibition of ovulation in
copper acetate-induced ovulation (Vohora, et al., 1973). LS seeds have been shown to contain
3.7 mg/g dry weight of lepidine with the highest content of lepidine in the plantlets at 10.4 mg/g
during the vegetative state (Pande, et al., 2002). Lepidine could be a possible alkaloid that lends
anti-ovulatory properties (Kumar & Sachin, 2013). To date, there have been no systematic
studies completed on the effects of lepidine on reproductive function. Further research is needed
to investigate if a higher concentration of LS seed aqueous extract is needed to yield antiovulatory effects. Interestingly, female mice that were cyclooxygenase 2 (COX-2) deficient
appeared to be infertile (Dinchuk, et al., 1995). LS seeds have been shown to have antiinflammatory properties (Raval, et al., 2009). Subsequently, LS seeds could have another
pathway yielding anti-ovulatory properties by inhibiting COX-2. The anti-inflammatory
mechanism for COX-1 or COX-2 inhibition specificity has not yet been elucidated for LS seeds.
Our results indicate that there was a strong feed aversion for rats being fed 15% LS seed
inclusion. This yielded a sharp decline in body weight for the LS-supplemented rats. The
aversion lessened after the rats became convinced the LS supplemented feed was safe as evident
in previous studies (Forbes, 2007). Importantly, after this feed aversion, feed intake became
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similar between control and LS included groups. Weight changes increased over time
concurrently between the two groups. These results were similar in broilers fed up to forty-two
days at 0, 0.75, 1.50 and 2.25% LS seed inclusion (Shawle, et al., 2016).
There was no effect of LS seed inclusion on adrenal gland, heart, liver, spleen or lungs.
This is in agreement with previous results obtained in Wistar rats fed 10% LS seed inclusion
(Datta et al., 2011). Similarly, LS supplementation at 2.25 % of broilers had no effect on heart
and liver weights (Shawle et al., 2016). We observed however a significant increase in brain
weight in rats fed 15% LS seed inclusion during weeks four, six and eight. It is unknown why the
brain weight increased. We speculate this may be due to water accretion in the brain. The exact
mechanism by which this might have occurred is not clear. Future research is needed to delineate
the molecular mechanisms surrounding the increased cerebral weight. There also was a
significant increase in pancreatic weight during week eight. We speculate this was due to
pancreatitis. Eddouks and Maghrani (2008) determined LS seeds to have hypoglycemic activity
with no plasma insulin changes while collecting blood samples during a four-hour period of
aqueous LS extract infusion. The authors attributed the hypoglycemic effects of LS seeds to be
extra-pancreatic occurring possibly by inhibiting renal glucose reabsorption. The hypoglycemic
state possibly caused a decreased release of pancreatic insulin secretion and therefore an increase
in pancreatic weight. Further research is needed to investigate the effects of chronic consumption
of LS seeds on pancreatic function.
In our hands, chronic LS feeding had no significant effect on paired testicular,
epididymides or seminal vesicle weight. However, the prostate gland showed a significant
decrease during weeks two and six for rats fed 15% LS seed and a nonsignificant decrease during
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weeks four and eight for the treatment group. It is of interest to note that these are testosterone
dependent organs displaying opposite weight changes. It is unclear why these differential weight
changes have occurred.
Histologically, there were no significant effect of LS supplementation on seminiferous
tubule diameters or germinal cell layer thickness. There was however, an effect of acute but not
chronic LS feeding on Leydig cell diameter. No significant Leydig cell diameter differences was
observed in week four, six and eight. In vitro testosterone production did not differ significantly.
There were also no significant changes in plasma testosterone. Therefore, our results provide no
support for the aphrodisiac claims of LS seed ingestion (Mali, et al., 2007) at 15% inclusion.
Future research should investigate the effect of different LS seed extracts on testosterone
production and plasma levels. The increase in fertility for males may be a testosteroneindependent function.
Chronic LS supplementation had neither stimulatory nor inhibitory effect on epididymal
sperm density. This is different from results obtained by Naji et al. (2013a, 2013b) that
investigated the effects of phenol and tocopherol extracts of LS seeds in male white rabbits. The
authors determined the extracts to increase sperm concentration in the cauda epididymis and
testis. The authors proposed the increased in sperm concentration was from the isothiocyanate or
phenolic compounds with antioxidant activity similar to results from Gonzales et al. (2006) using
Lepidium meyenii roots. The reason our results differed may be because Naji et al. (2013a,
2013b) utilized phenol and tocopherol extractions that would yield a more concentrated extract
of isothiocyante and phenolic compounds than our 15% inclusion of ground LS seeds. Christie
(2010) found that tocopherol may have a protective function towards sperm serving as an
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antioxidant. The extraordinary effects of antioxidants like vitamin E have been shown to protect
rabbit testes against lipid peroxidation and testosterone-induced lipid peroxidation (Aydilek,
Aksakal, & Karakilҫik, 2004). Vitamin supplementation in boars increased semen production
and percentage of motile sperm cells but did not affect sperm morphology or libido (Audet,
Laforest, Martineau, & Matte, 2004). This yields evidence that the antioxidants within LS seeds
can increase fertility in higher concentrations via different extracts.
Both acute and chronic LS feeding significantly increased kidney weight in our study.
Adam (1999) observed no renal abnormalities in Wistar rats fed 2% LS seed inclusion but at
50% LS seed inclusion there were significant deleterious effects on the kidneys. The deleterious
effects were less marked in rats fed 10% LS seed inclusion. In addition to the renal weight
increase, histological analysis showed the LS supplementation induced significant increase in
glomerulosclerosis and tubular degeneration throughout the duration of the study. Similar results
were observed in Wistar rats fed 50% LS seed inclusion (Adam, 1999). At 2.25% LS seed
inclusion in broilers, there was no kidney weight change (Shawle, et al., 2016).
Glomerulosclerosis presents with sclerosis of the glomerulus and an increase in matrix
(Sugahara, Hosaka, Mineshige, Kamiie, & Shirota, 2015). The increased matrix led to
significantly-expanded Bowman’s space. Ingestion of LS seeds is a concern because nearly 20%
of glomerular diseases are from glomerulosclerosis and glomerulosclerosis is a major cause of
end-stage renal disease (Chen, et al., 2016). This therefore suggests that, in our hands, LS
supplementation at 15% increases the susceptibility to glomerulosclerosis and represents a major
health concern.
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The weight increase can also be explained by significant presence of increased
glomerular hyperplasia and metaplasia of the Bowman’s capsule. There was also significant
increase in proximal and distal convoluted tubule diameter with significant tubular degeneration.
Similar tubular degeneration was seen in Wistar rat’s that were fed 50% LS seeds and less
marked in rats fed 10% LS seeds for three and six weeks and absent in rats fed 2% LS seeds
(Adam, 1999).
Interestingly, one study showed that ethanolic LS seed extract administration ameliorated
renal tubular dilation (Yadav & Srivastava, 2012) caused by the anticancer drug cisplatin
(Molitoris, Dahl, & Geerdes, 1992). Yadav et al. (2012) hypothesized the cisplatin induced
oxidative stress nephrotoxicity was decreased by the antioxidant properties of the ethanolic
extract of LS seeds.
Transforming growth factor-β1 (TGF-β1) is a cytokine involved with glomerular
extracellular matrix production in streptozotocin-induced diabetic rats (Schaan, et al., 2001).
TGF-β1 is responsible for the generation of glomerulosclerosis in diabetic rats (Bertoluci,
Schmid, Coimbra, & Lachat, 1996). In adult male Wistar rats, Eddouks et al. (2008) induced
diabetes via streptozotocin injection and lowered plasma glucose levels concurrent with
increased urinary glucose excretion over the course of fifteen days by administration of aqueous
LS seed extract. The author’s hypothesized the aqueous LS seed extract inhibits renal glucose
reabsorption. The diabetic rats treated with aqueous LS seed extract had similar urinary TGF-β1
levels to diabetic control rats. Both diabetic rat TGF-β1 levels did decrease after fifteen days.
Therefore, the TGF-β1 levels from the streptozotocin induced diabetic rats receiving aqueous LS
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seed extract may be masking the toxic effects of LS. In our study, there was a significant
presence of glomerulosclerosis and renal tubular degeneration after fourteen days.
Glomerulosclerosis and tubular atrophy are clinical manifestations of immunoglobulin A
nephropathy (IgAN) (Mizerska-Wasiak, et al., 2014). N-acetylgalactosamine exposure is crucial
to the pathogenesis of IgAN. Increased exposure to N-acetylgalactosamine is correlated with an
increased risk factor for glomerulosclerosis (Xu, et al., 2014). N-acetylgalactosamine is located
bound to the IgA1 hinge region on immunoglobulin A (Kerr, 1990). IgAN is characterized by the
deposition of polymeric IgA1 within the renal mesangial cells (Donadio & Grande, 1997). Allen
et al. (2001) and Hiki et al. (2001) demonstrated IgA1 molecules that had an aberrant Oglycosylation deposited within the renal mesangial cells. With this evidence LS seed ingestion
could result in the aforementioned renal toxicity by a(n) unknown phytochemical(s) in LS seeds
by cleaving N-acetylgalactosamine from IgA1. Future research is needed to investigate the
effects of LS seeds and IgA1 molecules.
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Chapter VII: Conclusion
Aqueous LS seed extract had no significant effect on GnRH, LH or FSH secretions
during preovulatory hormonal surge secretion. Aqueous LS seed supplementation demonstrated
a tendency to advance and attenuate a preovulatory GnRH surge. Although limited studies have
suggested an anti-ovulatory effect of LS seed ingestion, further research is needed to confirm
this. Further, whereas chronic LS seed supplementation lead to no deleterious effects on testes,
epididymides, seminal vesicles, adrenal glands, heart, liver, spleen and lungs, gross
histopathology was observed in the kidney indicating nephrotoxicity. Deleterious effects in the
weight of the prostate gland, brain and pancreas were also observed by chronic consumption of
LS seeds. Overall, these results indicate a cautionary approach to the consumption of LS seeds
for medicinal purposes because of a possible narrow therapeutic index.
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